Navigation Links
Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
Date:7/28/2009

PRINCETON, N.J., July 28 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Daniel E. Leone as Vice President of Business Development. Mr. Leone will be responsible for Laureate's worldwide business development activities, including sales and marketing. He will be supporting the company's contract development, manufacturing, and bioprocessing business.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

"We are pleased to welcome Dan to Laureate's Leadership Team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "Dan is a seasoned executive with more than 20 years of experience in business development and he brings an impressive background that includes broad international business development and management experience in contract manufacturing, pharmaceuticals and specialty chemicals. His capabilities include strong leadership, and strategic and organizational skills that have produced positive results in early stage and mature businesses."

Most recently Dan served as Executive Director of Contract Manufacturing at Ben Venue Laboratories where he was responsible for Sales, Marketing and New Business Development for its parenteral contract manufacturing services business. Prior to Ben Venue, Dan was the Vice President of Business Operations at Boehringer Ingelheim Chemicals where he was responsible for Sales, Marketing, New Business Development and Supply Chain Management for its active pharmaceutical ingredients business. Prior to BI, Dan held positions of increasing responsibility at Hoechst Corporation. While at Hoechst Dan served as their Global Director, Ventures in Hoechst's Research and Technology Division where he was responsible for general management of several early stage businesses. Dan earned an MBA from Duke University and Masters and Bachelors degrees in Chemical Engineering from Manhattan College.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact us at info@laureatepharma.com or visit www.laureatepharma.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Robert Broeze

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=84360


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
2. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
3. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
4. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
5. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
6. Laureate Announces Manufacturing Agreement with Tolerx
7. Laureate Pharma to Add More Manufacturing Capacity
8. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
9. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
10. Laureate Pharma Reports Record Growth for 2007
11. Laureate Pharma Appoints Gary Swan as Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a ... The tremendous growth is accounted to two main factors. The first is ... expanding network of vendors supplying FireflySci products all around the world. , 2016 was ...
(Date:1/19/2017)... 2017 BD (Becton, Dickinson and Company) (NYSE: ... will host a live webcast of its Annual Meeting of Shareholders ... The webcast can be accessed from the BD corporate website ... January 31, 2017. ... About BD BD is a global medical technology company ...
(Date:1/18/2017)... --  Parent Project Muscular Dystrophy (PPMD) , a nonprofit ... dystrophy (Duchenne) , today announced a $600,000 grant to ... (NJIT) and Talem Technologies (Talem) as part of the ... assist people living with Duchenne. PPMD is funding a ... computer, software, a force sensor and a motor – ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... announced that it has submitted a 510(k) to the FDA, requesting clearance of ... patent-pending functional electrical stimulation (FES) technology. , The submission marks a major ...
Breaking Biology Technology:
(Date:12/15/2016)... -- "Increase in mobile transactions is driving the growth ... is expected to grow from USD 4.03 billion in ... CAGR of 29.3% between 2016 and 2022. The market ... for smart devices, government initiatives, and increasing penetration of ... expected to grow at a high rate during the ...
(Date:12/8/2016)... , Dec. 8, 2016 Market Research Future published ... Market. The global Mobile Biometric Security and Service Market is expected ... to 2022. Market Highlights: ... , , Mobile Biometric ... due to the increasing need of authentication and security from unwanted ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market by ... Area, End User, And Region - Global Forecast to 2021", published by MarketsandMarkets, ... to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate (CAGR) ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):